HeartBeam Corp (BEAT) - Prakiraan wutah bathi kanggo taun ngarep

heartbeam.com - logo grafis emiten BEAT

The current valuation of HeartBeam, Inc. (BEAT) EPS growth for the coming year reflects expert expectations, with 21.90 representing the current metric. HeartBeam, Inc. (BEAT) revenues are based on the sale of compact 3D-ECG systems for the rapid diagnosis of myocardial infarctions. Business success relies on FDA approval and the accuracy of ischemia detection. Stable demand in cardiology protects financial results from macroeconomic downturns.

BEAT: Prakiraan wutah bathi kanggo taun ngarep HeartBeam Corp 04.07.2022 - 14.11.2026

heartbeam.com - rincian analitis lan metrik utama (BEAT)

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:BEAT, HeartBeam Corp
Produk merek heartbeam.com

The fundamental valuation of an asset is based on the business's ability to generate future cash flow. This indicator aggregates expert consensus forecasts for earnings per share growth rates; therefore, changes in analyst EPS growth estimates reflect market optimism regarding profitability. For HeartBeam, Inc. (BEAT), the dynamics of this metric depend directly on the pace of user base expansion and the acquisition of FDA certifications for its cloud software.

Perusahaan pesaing

REGN (Regeneron Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep IRTC|Prakiraan wutah bathi kanggo taun ngarep LNTH|MLYS - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep HTFL (HeartFlow Inc)|Prakiraan wutah bathi kanggo taun ngarep Kestra Medical Technologies, Inc. KMTS|ESPR - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Amarin Pharma (AMRN) - Prakiraan wutah bathi saben saham kanggo taun ngarep|AVR (anteristech.com) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Tenaya Therapeutics, Inc. - Dinamika bathi saben saham sing diarepake ing taun ngarep|CVRX (CVRx) - Prakiraan wutah bathi kanggo taun ngarep|Milestone Pharmaceuticals, Inc. (MIST) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Cardiol Therapeutics (CRDL)|Tenax Therapeutics Inc - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep ADGM (Adagio Medical Holdings)|BCDA - Prakiraan wutah bathi saben saham kanggo taun ngarep|VTAK: Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep ARCA Biopharma ABIO|ACST: Prakiraan wutah bathi kanggo taun ngarep|AVTE (Aerovate Therapeutics, Inc) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|VERV (Verve Therapeutics Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Windtree WINT